Sequential Addition of an Anthracycline-Based Regimen to Docetaxel as Neoadjuvant Chemotherapy in Patients with Operable Breast Cancer
Authors:
- Marie-Ange Mouret-ReynierMMMarie-Ange Mouret-Reynier
- Frédérique Penault-LlorcaFPFrédérique Penault-Llorca
- Marianne LeheurteurMLMarianne Leheurteur
- Rémi DelvaRDRémi Delva
- Bruno CoudertBCBruno Coudert
- Bernard LeducBLBernard Leduc
- Jacques DauplatJDJacques Dauplat
- Hervé CuréHCHervé Curé
- Philippe CholletPCPhilippe Chollet
- 1 August 2006
- journal article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 7 (3) , 262-269
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An UpdateJournal of Clinical Oncology, 2006
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Journal of Clinical Oncology, 2003
- Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast CancerJournal of Clinical Oncology, 2003
- Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III TrialJournal of Clinical Oncology, 2003
- Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18JNCI Monographs, 2001
- Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902Journal of Clinical Oncology, 2001
- Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter TrialJournal of Clinical Oncology, 2001
- Primary Systemic Therapy in Operable Breast CancerJournal of Clinical Oncology, 2000
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal of Cancer, 1994
- Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cmAnnals of Oncology, 1991